Skip to main content
fghjkjhb

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing mini-HTAs in Norway in November 2024

In November 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, gastrointestinal, in-vitro diagnostics, interventional radiology, men’s health, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway. Some examples are listed below: 

  • Pulmonary vein isolation with Pulsed Field Ablation;
  • Introduction of Berlin Heart EXCOR for long-term mechanical circulatory support in children with terminal heart failure;
  • Robot-assisted ultrasound on pregnant women;
  • Use of the artificial intelligence application BoneView (by Gleamer) for analysis of diagnostic images in suspected fractures;
  • Breathe Better – A digital tool to strengthen the health skills of people with chronic lung disease;
  • Use of artificial intelligence (icobrain MS) for annotation and reporting of MS plaques and volumetry;
  • MemoPlanner as a facilitation tool for coping with everyday life;
  • Trial of mobile patient monitoring in patients with a need for cEWS follow-up;
  • Assessment of models for Closed drug loop in Oslo University Hospital;
  • Artificial intelligence (AI)-based image interpretation for diabetic retinopathy;
  • Transarterial radioembolization of liver tumors;
  • Return of intestinal contents in patients with intestinal failure using The Insides System pump;
  • Removal of intestinal polyps;
  • Mobile Acetylcholinesterase Inhibitor Test Kit for the detection of nerve agents and other cholinesterase inhibitors;
  • Poly-marker in endometrial cancer to de-escalate treatment.

The full details in Norwegian can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.